The Trump administration is planning an Affordable Care Act replacement plan; a drug-resistant fungus has been spreading and causing severe issues for hospitals; protesters gather in Washington, DC, to criticize the FDA's handling of the opioid crisis.
Mick Mulvaney, acting White House chief of staff, says the Trump administration will release a plan to replace the Affordable Care Act “fairly shortly,” CNN reported. HHS Secretary Alex Azar and CMS Administrator Seema Verma joined White House aides and administration officials at Camp David on Saturday to outline the next moves for Trump’s healthcare proposal. Topics discussed included lowering drug prices, individual health insurance marketplaces, and messaging strategies. Mulvaney told Fox News Sunday believes the plan under development will provide GOP candidates with a plan they can discuss with voters while campaigning.
Infections caused by the fungus Candida auris, which affects people with weakened immune systems and is resistant to antifungal medications, have been quietly spreading around the world for over 5 years, The New York Times reported. The fungus was recently reported in New York, New Jersey, and Illinois after causing serious issues in Venezuela, Spain, Great Britain, India, Pakistan, and South Africa. The invasive fungus was found everywhere in the room of a patient who passed away at New York's Mount Sinai Hospital from a related infection after being hospitalized for 90 days. The hospital required special cleaning equipment and had to replace floor and ceiling tiles to fully eliminate the fungus.
Nearly 100 protesters gathered Friday in Washington, DC, to protest Scott Gottlieb, MD, on his final Day as FDA commissioner with an 800-pound heroin spoon stamped with the FDA’s logo, STAT News reported. The group called for the FDA to stop approving opioids and urged the agency to shift its focus towards encouraging the development of more drugs to treat addiction. The protesters’ chant echoed “200 dead every day, we blame the FDA.” However, the group delivered the spoon to the HHS headquarters, the Hubert H. Humphrey Building in Washington, DC, not the FDA complex in Silver Spring, Maryland.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More